Lowenstein Sandler advised Sonnet BioTherapeutics, while Sullivan & Worcester advised Chardan Capital Markets on the offering. Sonnet BioTherapeutics Holdings, Inc. (Nasdaq: SONN), a clinical-stage company developing...
Sonnet BioTherapeutics’ $5 Million Common Stock Offering
GTCR’s $1.33 Billion Investment in Tricentis
Kirkland & Ellis represented GTCR in the transaction, and Willkie Farr & Gallagher represented Insight Partners and Tricentis. GTCR, a leading private equity firm, announced its...
Palladyne AI’s $7 Million Common Stock Offering
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Palladyne AI Corp. (Nasdaq: PDYN and PDYNW), a developer of artificial intelligence software for robotic platforms...
Reuben Brothers’ $400 Million Acquisition of W South Beach
McDermott Will & Emery represented RFR Holding and Tricap in the sale of W South Beach. Reuben Brothers, a UK-based investment firm, has acquired the W...
WWEX Group’s $1.5 Billion Refinancing and Incremental Facilities
Weil advised Goldman Sachs and the other lead arrangers in the transaction. WWEX Group (owned by a consortium including CVC Capital Partners, Providence Equity Partners and...
Comvest Private Equity’s Acquisition of Riccobene Associates Family Dentistry
Holland & Knight advised Riccobene Associates Family Dentistry, while Akerman represented The Beekman Group in the deal. Riccobene Associates Family Dentistry, a portfolio company of New...
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
TGS ASA’s $550 Million Senior Secured Notes Offering
Gibson Dunn & Crutcher is advising TGS ASA on the offering. TGS ASA (TGS) (TGS) (“TGS” or the “Company”), a global leader in energy data and...
Bia Energy’s $8.5 Million Bridge Round
Wilson Sonsini Goodrich & Rosati advised Bia Energy on the transaction. Colombia-based Bia Energy announced that it completed a $8.5 million bridge investment round led by...
Pointwise Ventures LLC v. Syte – Visual Conception Ltd.
K&L Gates represented Syte – Visual Conception Ltd. in the case. Pointwise Ventures LLC filed a patent troll case in the Marshall Division of the Eastern...
Arrowhead Pharmaceuticals’ Lincense Collaboration Agreement with Sarepta Therapeutics
Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
L2 Point Management’ Closing of L2 Point Opportunities I
Proskauer advised L2 Point Management on the deal. L2 Point Management, LLC (“L2 Point”) announced the successful close of its inaugural structured equity fund, L2 Point...